Does SSDI Use Pre- or Post-Bronchodilator Spirometry Results?

If you're applying for SSDI benefits based on a lung condition, you've likely had spirometry testing — and you may have wondered whether the Social Security Administration looks at the numbers recorded before or after you use a bronchodilator inhaler. It's a precise but genuinely important question, because those two readings can look meaningfully different, and the one SSA relies on can affect how your condition is evaluated.

What Spirometry Measures and Why It Matters for SSDI

Spirometry is the standard pulmonary function test used to measure how much air you can forcefully exhale and how fast. The two values most relevant to SSDI are:

• FEV1 (Forced Expiratory Volume in one second) — how much air you push out in the first second
• FVC (Forced Vital Capacity) — the total volume of air exhaled after a maximum breath
• FEV1/FVC ratio — the proportion of total lung volume expelled in that first second

These numbers form the backbone of SSA's evaluation of chronic obstructive pulmonary disease (COPD), asthma, chronic bronchitis, emphysema, and related respiratory impairments.

SSA's Official Position: Post-Bronchodilator Values

For most respiratory listings, SSA uses post-bronchodilator spirometry results — meaning the values recorded after the patient has inhaled a bronchodilator medication. This approach reflects the underlying, treated baseline of lung function rather than a snapshot that might artificially appear worse because the airways were temporarily more constricted.

The relevant SSA listing is Listing 3.02 (Chronic Respiratory Disorders), which covers conditions like COPD and restrictive lung disease. When SSA evaluates whether your spirometry results meet or equal a listed impairment, the agency specifically looks at post-bronchodilator FEV1 and FVC values measured against tables based on your height.

This matters in a practical sense: post-bronchodilator readings tend to be higher (showing better lung function) than pre-bronchodilator values. So if your post-bronchodilator numbers still fall within the impairment thresholds SSA uses, that's considered a stronger indicator of a genuine, persistent limitation.

Why the Distinction Exists 🫁

Pre-bronchodilator values can reflect temporary bronchoconstriction — the kind of airway narrowing that responds well to medication. SSA is generally trying to evaluate your maximum functional capacity after medically appropriate treatment. Using post-bronchodilator numbers prevents an overestimate of impairment severity in cases where a simple inhaler substantially reverses the restriction.

That said, bronchodilator response itself can be medically significant. A large difference between pre- and post-bronchodilator numbers (called bronchodilator reversibility) is a diagnostic indicator relevant to conditions like asthma versus COPD. Your treating physician's interpretation of that gap matters to the clinical picture, even if SSA's listings are anchored to the post-bronchodilator result.

What This Means at Different Stages of an SSDI Claim

Variables That Shape How Your Spirometry Results Are Used

Even with a clear rule favoring post-bronchodilator values, several factors influence how those results actually affect your claim:

Test quality and effort. SSA requires spirometry to meet ATS/ERS acceptability and reproducibility standards. If the test wasn't performed correctly — inconsistent effort, inadequate attempts, equipment issues — the results may be considered unreliable. A poorly administered test, even one with striking numbers, may not carry the weight you'd expect.

Your height. The FEV1 and FVC thresholds in Listing 3.02 are scaled to height. Two people with identical raw spirometry values can have different listing outcomes based on their height measurements.

Age and sex. Predicted normal values used in interpretation account for age and sex, which affects how your results are contextualized in the overall medical record.

Condition diagnosis. Listing 3.02 covers obstructive and restrictive patterns differently. The specific numbers required vary depending on whether your impairment is primarily obstructive (like COPD) or restrictive (like pulmonary fibrosis).

Frequency and recency. Lung function can decline over time. A spirometry result from several years ago may not reflect current severity. SSA evaluates the longitudinal record, and more recent testing typically carries more weight.

Medical opinions. A pulmonologist's interpretation of your spirometry — including comments about effort, consistency, and clinical correlation — becomes part of the evidentiary record SSA weighs.

When Spirometry Alone Isn't the Whole Picture

Not every respiratory SSDI claim is decided at the listing level. Even if your spirometry doesn't meet Listing 3.02's specific thresholds, SSA may still find you disabled through a Residual Functional Capacity (RFC) assessment. RFC looks at what you can actually do in a work setting — how far you can walk, whether you can work around dusts or fumes, whether you need supplemental oxygen — and compares that against jobs that exist in significant numbers nationally.

In those cases, spirometry is one piece of evidence among many, which may include six-minute walk test results, oxygen saturation readings, treatment history, and your own reported functional limitations.

The rule about post-bronchodilator values is clear. How that rule applies to a specific set of test results, in the context of a specific person's medical record, work history, and claim stage — that's where the landscape becomes individual.